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One of the most characteristic features of the 
mucosal immune system of most mammals is 
the dominant presence of SAbs, particularly se-
cretory IgA (SIgA), an antibody class unique to 
the mucosae. At least 80% of all Ig-producing 
plasma cells in the body are found in the intes-
tinal lamina propria, and most of these cells 
produce polymeric IgA (pIgA; mainly as di-
mers) (1, 2). Both pIgA and pentameric IgM 
are actively transcytosed across the secretory 
epithelium that lines the mucosal surfaces to 
external secretions after binding to the poly-
meric Ig receptor (pIgR), a glycoprotein ex-
pressed on the basolateral surface of secretory 
columnar and crypt epithelial cells, also called 
membrane secretory component (3–6). Some 
40 mg SIgA kg-1 body weight is transported 
to the gut lumen by the pIgR every day in a 
healthy adult human (7). The development of 
the gastric-associated lymphoid tissue (GALT) 
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and the production of IgA is initiated by col-
onization of the gut with commensal organ-
isms (8). Neonates, in which SIgA antibodies 
are barely detectable, depend on maternal IgG 
transferred through the placenta, and a supply 
of SAbs (mainly SIgA) from breast milk pro-
viding passive immunization of the gut. Sim-
ilarly, colonization of germ-free mice with 
commensal bacteria stimulates the develop-
ment of an otherwise undeveloped immune 
system and results in the production of IgA 
(9). Monoassociation of germ-free mice with 
commensal microbes demonstrated that ≥85% 
of IgA produced by these animals was not re-
active with the colonizing bacterium, and this 
IgA is referred to as natural IgA or innate IgA 
(9–11). The origin, requirements for produc-
tion, and the specifi  city of innate IgA are the 
subject of ongoing debate (11–13). It has been 
shown that innate IgA originates from both 
conventional B2 B cells and CD5+ B1 B cells 
(11, 14, 15). B1 cells, unlike B2 cells, do not 
require cognate interaction with CD4+ T cells 
and   germinal center reactions in Peyer’s patches 
(PP), but are thought to depend on “bystander” 
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The production of IgA is induced in an antigen-unspecifi  c manner by commensal fl  ora. 
These secretory antibodies (SAbs) may bind multiple antigens and are thought to eliminate 
commensal bacteria and self-antigens to avoid systemic recognition. In this study, we 
addressed the role of “innate” SAbs, i.e., those that are continuously produced in normal 
individuals, in protection against infection of the gastrointestinal tract. We used polymeric 
immunoglobulin receptor (pIgR−/−) knock-out mice, which are unable to bind and actively 
transport dimeric IgA and pentameric IgM to the mucosae, and examined the role of innate 
SAbs in protection against the invasive pathogen Salmonella typhimurium. In vitro experi-
ments suggested that innate IgA in pIgR−/− serum bound S. typhimurium in a cross-reactive 
manner which inhibited epithelial cell invasion. Using a “natural” infection model, we 
demonstrated that pIgR−/− mice are profoundly sensitive to infection with S. typhimurium 
via the fecal-oral route and, moreover, shed more bacteria that readily infected other 
animals. These results imply an important evolutionary role for innate SAbs in protecting 
both the individual and the herd against infections, and suggest that the major role of 
SAbs may be to prevent the spread of microbial pathogens throughout the population, 
rather than protection of local mucosal surfaces.
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CD4+ T cell help in the form of cytokines (IL-5, IL-6, 
IL-10) only to produce IgA (12, 14). However, a report 
by MacPherson et al. demonstrated that IgA responses to 
commensal bacteria occur in specifi  c pathogen-free TCR-
β−/−δ−/− mice, suggesting that a CD4+ T cell–independent 
pathway for production of IgA may exist (13). B1 cells may 
be stimulated in an antigen-specifi  c manner through the 
BCR (13), but considering the large proportion of total 
IgA that does not bind the commensal bacterium that was 
used to colonize monoassociated germ-free mice, it is more 
likely that polyclonal stimulation of B1 cells, through for 
instance Toll-like receptors, induces production of innate 
IgA (10, 11, 16).
The specifi  city of innate IgA that is secreted into the mu-
cosal lumen is largely unknown, although SIgA present in 
intestinal washings and saliva has been shown to react with 
commensal bacteria and autoantigens (13, 17, 18). Because of 
its ability to bind multiple antigens, innate IgA has been re-
ferred to as polyreactive (19, 20). A recent study, however, 
has shown a restricted use of VH genes that harbor somatic 
mutations by IgA-producing plasma cells in the gut, suggest-
ing that although the IgA repertoire may be   restricted and 
not driven by affi   nity maturation the use of such VH genes 
would generate antibodies with a distinct specifi  city (21).
It has been suggested that SAbs specifi  c for commensal 
organisms function by immune exclusion, preventing the 
translocation of luminal fl  ora and induction of systemic im-
mune reactions (1, 2, 22). However, a role for innate SAbs 
in protection of the gut against pathogenic organisms is less 
clear. In this study, pIgR−/− mice, which are unable to bind 
and actively transport dimeric IgA and pentameric IgM to the 
mucosae (5, 6), were used to examine the role of innate SAbs 
in protection against the invasive gastrointestinal pathogen 
Salmonella typhimurium.
RESULTS AND DISCUSSION
Innate SAbs inhibit epithelial cell invasion by S. typhimurium
S. typhimurium is an invasive enteric pathogen that preferen-
tially uses the M cells of the PP as portals of entry, after which 
the bacteria spread to the mesenteric LN and in mice, dis-
seminate to cause a systemic disease (23). We investigated 
whether innate SAbs block invasion of the gut epithelium by 
comparing the number of bacteria detected in the PP and 
small intestinal mucosa of B6 and pIgR−/− mice 6 or 12 h af-
ter oral infection with 107 CFUs S. typhimurium. The com-
bined results of three independent experiments showed that 
S. typhimurium invasion is signifi  cantly increased (P = 0.011) 
in pIgR−/− mice (137 ± 129) compared with B6 mice (59 ± 
88) (Fig. 1 A).
In pIgR−/− mice, pIgA destined for secretion into the 
mucosal lumen accumulates in the blood, resulting in 100-
fold greater serum levels than in B6 mice, whereas IgG and 
IgM concentrations are similar (5, 6). The use of pIgR−/− se-
rum allowed us to examine the interaction between “accumu-
lated” innate SIgA in its dimeric form (6) and S. typhimurium. 
We used an in vitro invasion assay to demonstrate that serum 
from pIgR−/− mice blocked Madine-Darby canine kidney 
(MDCK) epithelial cell invasion by S. typhimurium (Fig. 1 B). 
After preincubation of the MDCK cells with serum obtained 
Figure 1.  Innate IgA inhibits S. typhimurium invasion. (A) Naive 
mice were orally infected with 107 CFUs S. typhimurium. Shown are the 
numbers of S. typhimurium detected in PP 6 or 12 h after oral infection, 
or in ileal mucosa 12 h after infection. Presented are the combined results 
of three independently performed experiments. *P = 0.011. (B) An in vitro 
invasion assay was used to determine the ability of serum from naive 
B6 (hatched columns) or pIgR−/− mice (black columns) to inhibit 
S. typhimurium invasion. Presented is the mean invasion ± 1 SD of tripli-
cate cultures of one representative out of three performed experiments. 
*P = 0.04; **, P < 0.001. (C) Goat anti–mouse IgG (hatched columns), 
goat anti–mouse IgA (black columns), or culture medium (white columns) 
was added to serum from pIgR−/− mice before use in an in vitro invasion 
assay. As controls, B6 serum or goat antibodies added to the assay in the 
absence of serum was used. Presented is the mean invasion ± 1 SD of 
triplicate cultures. *, P = 0.4; **, P = 0.01. (D) Normal (white bars) and 
preabsorbed serum (hatched bars) from B6 or pIgR−/− mice (pools of 
three) was assayed for its ability to block invasion of MDCK cells by 
  S. typhimurium . Shown is the mean invasion ± 1 SD of quadruplicate 
cultures of one representative out of six independently performed experi-
ments. *, P = 0.04; **, P = 0.01. (E) ELISA was used to determine the IgA 
titers specifi  c for gut microfl  ora in normal (white bars) and preabsorbed 
(hatched bars) serum from pIgR−/− mice. Symbols represent serum pools 
formed from three or four mice (n = 10 in total). The dotted line indicates 
the detection limit of the assay.JEM VOL. 203, January 23, 2006  23
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from naive pIgR−/− mice, a signifi  cantly reduced number of 
invaded S. typhimurium was detectable (7.6 × 104 ± 1.5 × 
104) compared with the eff  ect of serum from naive B6 mice 
(2 × 105 ± 9 × 104; P = 0.04) or with no serum control (3 × 
105 ± 3 × 104; P < 0.001). Similar results were obtained with 
heat-inactivated serum (unpublished data), suggesting that IgG 
antibodies inducing complement activation did not contrib-
ute to the obtained results. The inhibitory eff  ect of pIgR−/− 
serum was abolished by the addition of goat anti–mouse IgA 
antibodies but not by goat anti–mouse IgG antibodies, sug-
gesting that IgA in pIgR−/− serum was inhibiting invasion of 
MDCK cells by the bacteria (Fig. 1 C).
The production of IgA is induced in an antigen- unspecifi  c 
manner by commensal fl  ora (9–11). Although some reports 
have suggested that SIgA is polyreactive in nature, other fi  nd-
ings point to a restricted specifi  city that may be cross-  reactive 
(13, 17–19, 21, 24). In further experiments, we examined the 
reactivity of dIgA in pIgR−/− serum with S. typhimurium. 
Serum samples were preabsorbed against S. typhimurium by 
overnight incubation at 4°C, which resulted in a nonsignif-
icant reduction in the amount of total IgA in the samples 
(6.13 ± 1.6 mg/ml versus 4.31 ± 0.85 mg/ml in preabsorbed 
serum). Fig. 1 D shows that compared with untreated pIgR−/− 
serum, preabsorbed pIgR−/− serum was no longer able to ef-
fectively inhibit invasion of MDCK cells, suggesting that a 
small proportion of total pIgA was able to bind S. typhimurium 
and block host cell invasion.
In previous studies, we characterized the composition of 
the ileal fl  ora of pIgR−/− mice, which was similar to that of 
B6 mice (25). Subsequent studies demonstrated that pIgR−/− 
have increased levels of serum IgA specifi  c for members of 
the gut fl  ora (unpublished data). To further investigate the 
polyreactive nature of pIgA in serum from pIgR−/− mice, 
isolated species of normal gut fl  ora were cultured (25; unpub-
lished data) and used as antigens in an ELISA to measure 
binding of normal pIgR−/− serum and pIgR−/− serum pre-
absorbed against S. typhimurium. Fig. 1 E shows that after 
preabsorption binding of pIgR−/− serum to fl  ora isolates was 
either increased or not altered.
In contrast to fi  ndings by Bouvet et al. (19, 24), preab-
sorbtion of pIgR−/− serum with S. typhimurium only removed 
a small fraction of the total IgA and did not reduce the bind-
ing to other commensals. SIgA forms large multivalent com-
plexes with mucins and/or pFv after secretion (26), which 
may aff  ect the quantitative analysis of binding of SIgA to 
  antigens. Whereas we used serum samples containing dIgA, 
Bouvet et al. used samples of saliva and gut washings contain-
ing large aggregates of SIgA, and preabsorbing to a cross-reac-
tive antigen may therefore have resulted in removal of a large 
proportion of IgA. Collectively, our results suggest that pIgA 
in serum of pIgR−/− mice is not polyreactive but restricted 
in nature, and some of the innate pIgA antibodies are able to 
bind S. typhimurium in a cross-reactive manner. Further in-
vestigations which are beyond the scope of this paper, e.g., 
analysis of IgVH gene usage and the use of Ig allotype chime-
ric mice (15), may provide more insight into the exact nature 
and origin of the dIgA that binds S. typhimurium.
pIgR−/− mice are more susceptible to infection with 
S. typhimurium
We further investigated whether the increased microbial in-
vasion in vivo as a result of lack of innate SAbs augmented 
susceptibility of pIgR−/− mice to infection with virulent 
S. typhimurium. By orally infecting naive mice with decreasing 
doses of S. typhimurium and monitoring their survival, we fi  rst 
determined whether the lack of SAbs in pIgR−/− mice ren-
ders these animals more sensitive to infection with virulent 
bacteria than wild-type B6 mice (Fig. 2). At an oral dose of 
106 or 105 CFUs, pIgR−/− and B6 mice were equally suscep-
tible to infection. However, infection of pIgR−/− mice with 
104 CFUs S. typhimurium resulted in 100% mortality, whereas 
this dose was lethal in only 20% of B6 mice. Although this 
diff  erence in mortality of pIgR−/− mice compared with B6 
mice was demonstrated using a low inoculation dose (Fig. 2), 
the in vivo invasion experiments (Fig. 1 A) were performed 
with a higher infectious dose to enable recovery of intracellu-
lar bacteria within 6 h after infection from the gut tissues (27). 
Collectively though, these results strongly suggest that innate 
SAbs protect mice against pathogenic bacterial invasion.
Innate SAbs reduce spread of S. typhimurium during 
fecal-oral transmission
We subsequently wished to mimic the natural fecal-oral route 
of transmission of S. typhimurium infection by cohousing 
Figure 2.  The S. typhimurium LD50 is reduced in pIgR−/− mice. Groups 
of fi  ve naive B6 (■) or pIgR−/− mice (○) were orally infected with either 
106 (A), 105 (B), or 104 (C) CFUs S. typhimurium. For ethical reasons, mice were 
killed when they became moribund; these mice were deemed “nonsurvivors.”24   SECRETORY ANTIBODIES PROVIDE HERD IMMUNITY | Wijburg et al.
orally infected mice with naive animals. These experiments 
were performed with three cages in which one orally in-
fected B6 mouse was cohoused with two naive B6 and two 
naive pIgR−/− mice, and with three cages in which one 
orally infected pIgR−/− mouse was cohoused with two naive 
B6 and two naive pIgR−/− mice. B6 mice infected with 
S. typhimurium shed 4 × 104 (±5 × 104) bacteria 1 d after in-
fection; this increased to 2 × 105 (±700) bacteria at day 8 
(Fig. 3 A). One out of three orally infected B6 mice was 
shedding signifi  cantly higher numbers of bacteria on day 5 af-
ter infection before it became moribund and was killed, result-
ing in an increased average bacterial count (106 ± 1.8 × 106) 
in the feces on this day. All infected B6 mice had succumbed 
to the infection by day 9 after oral inoculation (Fig. 3 C).
Only one out of the six naive B6 mice cohoused with the 
orally inoculated B6 mice acquired the infection and had de-
tectable bacteria in its feces on day 9 but none of them died 
(Fig. 3 C). Conversely, three out of six naive pIgR−/− mice 
cohoused with the orally infected B6 mice started shedding 
the S. typhimurium at day 5 after infection, and the number of 
bacteria shed in the feces rapidly increased to  8 × 106 bac-
teria around day 9 after infection (Fig. 3 A); these mice all 
became moribund by day 15 (Fig. 3 C).
The number of bacteria detected in feces of orally inocu-
lated pIgR−/− mice (Fig. 3 B) was at any time point signifi  -
cantly (P < 0.01) higher than that in feces of B6 mice (Fig. 
3 A), starting at 2 × 106 (±2 × 105) bacteria one day after 
infection, and increasing to  6.5 × 107 (±2 × 106) bacteria 
on day 7 and 8 after infection (Fig. 3 B), at which point the 
animals had all been killed (Fig. 3 D). This suggested that in 
the absence of SAbs, the number of replicating S. typhimurium 
was dramatically increased.
Naive pIgR−/− mice cohoused with the S. typhimurium–
infected pIgR−/− mice rapidly acquired the infection and 
were shedding bacteria in their feces as early as 1 d after being 
cohoused with the orally inoculated pIgR−/− mice. After 5 d 
of cohousing, the naive pIgR−/− mice were shedding >107 
bacteria (Fig. 3 B), and by day 11 all had succumbed to the 
infection (Fig. 3 D). Interestingly, naive B6 mice cohoused 
with orally infected pIgR−/− mice were also more sensitive 
to the infection compared with cohousing with orally in-
fected B6 mice, suggesting that the lower number of bacteria 
shed from B6 mice less readily infected other animals com-
pared with bacteria shed from pIgR−/− mice. S. typhimurium 
was detectable in feces of three out of six B6 mice cohoused 
with infected pIgR−/− mice (Fig. 3 B), and the infection was 
lethal for these mice (Fig. 3 D).
It has been demonstrated that circulating natural IgM 
  antibodies can protect against pathogenic microorganisms 
(28). Natural (or innate) SIgA production is induced by col-
onization with commensal fl  ora (9–12), and SAbs are thought 
to act by “immune exclusion” or “immune elimination” (1, 
2, 19, 22). Because of its ability to bind multiple antigens, 
whether in a restricted or polyreactive manner, binding of 
innate dIgA to commensal fl  ora or autoantigens and subse-
quent removal from the lamina propria via transport by the 
pIgR may prevent systemic recognition and undesirable 
pathological immune responses. In support of this hypothesis 
is the fi  nding that SIgA in breast milk is reactive with mem-
bers of the mother’s gut microbiota that were present in 
the third trimester and at birth, providing the neonate pro-
tection against commensal organisms while the GALT is 
  undeveloped (8).
In line with this concept, our studies show that the large 
amounts of innate SAbs normally actively exported into the 
gut lumen by the pIgR provide a primitive type of front line 
defense against invading bacterial pathogens in the naive host. 
Our data demonstrate for the fi  rst time that, in the absence of 
SAbs, increased numbers of S. typhimurium invade the gastro-
intestinal epithelium, suggesting that innate SAbs normally 
present in the gut block bacterial adhesion and penetration. 
Indeed, our in vitro experiments verifi  ed that serum obtained 
from naive pIgR−/− mice, which contains pIgA that is nor-
mally destined for secretion to the mucosae (5, 6), binds to 
S. typhimurium in a cross-reactive manner and inhibits the in-
vasion of MDCK cells by S. typhimurium.
More importantly, however, our study shows that the in-
nate SAbs may also reduce the shedding of pathogens and the 
spread of infections to other individuals which may not only 
Figure 3.  Naive pIgR−/− mice are susceptible to “natural” infec-
tion with virulent S. typhimurium. One B6 mouse (□, A) or one 
pIgR−/− mouse (○, B) was orally inoculated with S. typhimurium and 
cohoused with naive B6 mi ce (■) and naive pIgR−/− mice (●). The course 
of the infection in all mice (n = 3, orally inoculated mice; n = 6, naive 
mice) was followed by measuring the number of bacteria shed in feces. 
Mice were killed when they became moribund, and the survival was re-
corded (C and D). The experiment was performed with three cages for 
each strain of mice, and the data represent the mean ± 1 SD.JEM VOL. 203, January 23, 2006  25
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be because of increased numbers of bacteria, but could also 
be the result of the absence of a SAb “coat” on the excreted 
bacteria, which may normally prevent the bacteria from in-
vading a new host (9, 29, 30). Therefore, we propose that al-
though innate SAbs may protect locally at mucosal surfaces 
their major role may be to prevent the spread of pathogens 
throughout the population. This may explain why the im-
mune system has evolved to produce much larger amounts of 
IgA than any other Ig class, and why such large amounts of 
SAbs are continuously transported across the mucosae into 
external secretions and breast milk.
In conclusion, our data demonstrates that the innate SAb 
system, which in evolutionary terms is considered a primitive 
front line defense against induction of autoimmunity and in-
vasion by microbial pathogens (19), is crucial for both the 
  individual host and its herd. This fi  nding has important im-
plications for the development of novel immunotherapeutics 
designed to protect against pathogens that invade via the mu-
cosae, which are often devised to activate the production of 
antigen-specifi  c SIgA while ignoring the protective roles of 
innate SAbs.
MATERIALS AND METHODS
Animals. pIgR−/− mice were generated on a pure C57BL/6 (B6) genetic 
background as previously described (6). All mice were bred and reared under 
conventional conditions at the animal facility of The University of Mel-
bourne, Department of Microbiology and Immunology. Mice were age and 
sex matched for each experiment, and used at 6–8 wk of age. All animal ex-
periments were approved by The University of Melbourne Animal Ethics 
and Experimentation Committee, and complied with the Prevention of 
Cruelty to Animals Act (1986) and the National Health and Medical Re-
search Council (NHMRC) Australian Code of Practice for the Care and 
Use of Animals for Scientifi  c Purposes (1997).
Oral infection of mice with S. typhimurium. In this study, mice were 
orally infected with the virulent S. typhimurium strain SL1344 as described 
before (27).
Natural S. typhimurium infection model. To mimic the natural fecal-oral 
route of S. typhimurium transmission, a single mouse was infected with 107 
CFU S. typhimurium SL1344 by oral gavage and placed in a cage with naive 
animals. The acquisition and development of S. typhimurium infection in the 
naive animals was monitored by detection of S. typhimurium in feces. Ab-
sence of fecal S. typhimurium was confi  rmed before the start of each experi-
ment in all animals.
Bacterial colonization of organs. The number of live S. typhimurium in 
PP or entire small intestines was determined by plating serial dilutions of 
the homogenates on LB agar plates containing streptomycin, as described 
previously (27).
Shedding of S. typhimurium was determined by counting the number of 
bacteria in fresh fecal extracts. Individual mice were placed in clean boxes, 
and the collected fecal pellets were weighed, dissolved in sterile PBS (100 
mg/ml), and vortexed vigorously. Serial dilutions were plated on selective 
indicator media (DCA and MacConkey agar plates containing streptomycin) 
to enumerate the number of S. typhimurium in the samples.
Invasion assays. Invasion of MDCK cells by S. typhimurium SL1344 was 
determined as described before (27). In brief, monolayers of MDCK cells 
were infected with mid-log growth phase S. typhimurium at multiplicity of 
infection of 10. Serial dilutions of serum, pooled from three naive B6 or 
pIgR−/− mice, were added to the MDCK cells 5 min before addition of the 
bacteria. After 1 h, MDCK cells were washed and incubated for 1.5 h with 
culture media containing 100 μg/ml gentamicin to kill extracellular bacteria. 
After this period, cells were lysed with 0.1% (wt/vol) Triton X-100 in PBS, 
and the number of bacteria present in the lysates was determined by viabil-
ity   count. Preabsorbed serum was prepared by incubating the serum with 
S. typhimurium SL1344 for 12 h at 4°C while rotating, after which the bacte-
ria were removed by centrifugation. In some experiments, 1 mg of goat 
anti–mouse IgG or goat anti–mouse IgA (Sigma-Aldrich), diluted in culture 
media, was mixed with 200 µl serum before use in the assay.
Statistical analysis. The nonparametric two-tailed Mann-Whitney U test 
was used for statistical analysis of the results. Diff  erences were considered 
signifi  cant when P < 0.05.
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